Page 3 - Ancer Prostate News Today

Exercising regularly was associated with lower all-cause and cancer-specific mortality risk in an analysis of more than 11,000 long-term cancer survivors.

Evidence is mounting for an MRI-first screening approach to avoid biopsies. But can MRI stand alone?

Clinicians anticipate the newest way to treat a common cause of urinary symptoms in older men.

A recent meta-analysis addresses controversies surrounding the relevance of biochemical recurrence (BCR) as a surrogate endpoint for overall survival in trials of localized disease.

Despite its promise, PRS testing is not routine. The central debate about PRS lies in whether the risk score can predict who will develop prostate cancer that needs to be treated and who wont.

AI chatbots can give accurate information on common questions about cancer but may fall short when providing accurate cancer treatment recommendations, new research suggests.

The findings challenge a common theory that depression and anxiety increase cancer risk and should "change current thinking," they argue.

A validation study found that a simple urine test can accurately diagnose urothelial carcinoma and predict a patients risk for recurrence.

The debate persists as to whether these conditions are on the same spectrum or should be separated.

Rates of cancer screening and diagnoses appear to increase in the first year of Medicare coverage, new data show.